{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:03:50Z","timestamp":1792008230293,"version":"4.4.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021201","name":"European Academy of Dermatology and Venereology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021201","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jid.2026.03.035","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T21:15:38Z","timestamp":1781126138000},"page":"2083-2093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pathogenesis of cutaneous T-cell lymphoma: Malignant inflammation, immune reprogramming, and microenvironmental drivers"],"prefix":"10.1016","volume":"146","author":[{"given":"Joana","family":"Calv\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Iselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Wasmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Furtm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chella Krishna","family":"Vadivel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Bataiosu-Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terkild B.","family":"Buus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"\u00d8dum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Gon\u00e7alo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5478-8735","authenticated-orcid":false,"given":"Emmanuella","family":"Guenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2026.03.035_bib1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jaci.2024.09.004","article-title":"Single-cell sequencing delineates T-cell clonality and pathogenesis of the parapsoriasis disease group","volume":"155","author":"Alkon","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2026.03.035_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.imlet.2018.05.001","article-title":"Targeting the CD73-adenosine axis in immuno-oncology","volume":"205","author":"Allard","year":"2019","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jid.2026.03.035_bib3","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The Tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr Biol"},{"key":"10.1016\/j.jid.2026.03.035_bib4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/pathogens13030184","article-title":"The complex role of infectious agents in human cutaneous T-cell lymphoma pathogenesis: from candidate etiological factors to potential therapeutics","volume":"13","author":"Angelova","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.jid.2026.03.035_bib5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jid.2020.06.034","article-title":"Cancer-associated fibroblasts in mycosis fungoides promote tumor cell migration and drug resistance through CXCL12\/CXCR4","volume":"141","author":"Aronovich","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jid.2024.08.015","article-title":"Cutaneous T-cell lymphoma and dupilumab use: a multifactorial and complex story","volume":"145","author":"Beylot-Barry","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib7","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1158\/2159-8290.CD-24-1856","article-title":"Divergent evolution of malignant subclones maintains a balance between induced aggressiveness and intrinsic drug resistance in T-cell cancer","volume":"15","author":"Buus","year":"2025","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2026.03.035_bib8","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jaci.2024.10.028","article-title":"Integrative epidemiology and immunotranscriptomics uncover a risk and potential mechanism for cutaneous lymphoma unmasking or progression with dupilumab therapy","volume":"155","author":"Cabrera-Perez","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2026.03.035_bib9","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.jid.2022.07.037","article-title":"Exploring the nonlymphocytic cutaneous microenvironment in advanced cutaneous T-cell lymphomas using single-cell RNA sequencing","volume":"143","author":"Calugareanu","year":"2023","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"S\u00e9zary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib11","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2026.03.035_bib12","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.4049\/jimmunol.176.7.4431","article-title":"The vast majority of CLA+ T cells are resident in normal skin","volume":"176","author":"Clark","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jid.2026.03.035_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003008","article-title":"Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients","volume":"4","author":"Clark","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2026.03.035_bib14","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/cncr.32665","article-title":"Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the State of Georgia","volume":"126","author":"Clough","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.jid.2026.03.035_bib15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/bjd\/ljaf001","article-title":"Preclinical in vitro and in vivo evidence for targeting CD74 as an effective treatment strategy for cutaneous T-cell lymphomas","volume":"192","author":"Costanza","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/bjd.13054","article-title":"Expression dynamics of CXCL12 and CXCR4 during the progression of mycosis fungoides","volume":"171","author":"Daggett","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2024.106871","article-title":"Pathophysiology of cutaneous T-cell lymphomas: perspective from a French referral centre","volume":"268","author":"De Masson","year":"2024","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jid.2026.03.035_bib111","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaad.2012.12.975","article-title":"Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma","volume":"69","author":"DeSimone","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1255859","article-title":"Modulation of the skin microbiome in cutaneous T-cell lymphoma delays tumour growth and increases survival in the murine EL4 model","volume":"15","author":"Dey","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2026.03.035_bib19","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3390\/cancers15030746","article-title":"Mycosis fungoides and S\u00e9zary syndrome: microenvironment and cancer progression","volume":"15","author":"Dobos","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jid.2026.03.035_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00403-019-02015-7","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in erythrodermic cutaneous T-cell lymphoma (CTCL) patients","volume":"312","author":"Emge","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2026.03.035_bib109","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jid.2017.10.028","article-title":"Role of dysregulated cytokine signaling and bacterial triggers in the pathogenesis of cutaneous T-cell lymphoma","volume":"138","author":"Fanok","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib22","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1046\/j.1523-1747.2002.19610.x","article-title":"Increased CCR4 expression in cutaneous T cell lymphoma","volume":"119","author":"Ferenczi","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib23","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.3390\/cells10113176","article-title":"Role of AHR ligands in skin homeostasis and cutaneous inflammation","volume":"10","author":"Fern\u00e1ndez-Gallego","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jid.2026.03.035_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0092-8674(00)80059-8","article-title":"CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs","volume":"99","author":"F\u00f6rster","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jid.2026.03.035_bib25","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1158\/1078-0432.CCR-05-1513","article-title":"Presence of circulating CCR10+ T cells and elevated serum CTACK\/CCL27 in the early stage of mycosis fungoides","volume":"12","author":"Fujita","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2026.03.035_bib26","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1182\/blood-2014-07-590398","article-title":"Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation","volume":"125","author":"Geskin","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fonc.2019.00300","article-title":"Environmental and other extrinsic risk factors contributing to the pathogenesis of cutaneous T cell lymphoma (CTCL)","volume":"9","author":"Ghazawi","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.jid.2026.03.035_bib28","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1182\/bloodadvances.2021006512","article-title":"CCR8 is a new therapeutic target in cutaneous T-cell lymphomas","volume":"6","author":"Giustiniani","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jid.2026.03.035_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.2022016690","article-title":"Malignant T cells induce skin barrier defects through cytokine-mediated JAK\/STAT signaling in cutaneous T-cell lymphoma","volume":"141","author":"Gluud","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/bjd\/ljae441","article-title":"Haematogenous seeding in mycosis fungoides and S\u00e9zary syndrome: current evidence and clinical implications","volume":"192","author":"Gniadecki","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib31","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.jid.2024.03.022","article-title":"From molecules to microbes: tracing cutaneous T-cell lymphoma pathogenesis through malignant inflammation","volume":"144","author":"Gordon","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib32","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1158\/1078-0432.CCR-12-3488","article-title":"TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma","volume":"19","author":"Guenova","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2026.03.035_bib110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/13543784.2014.876407","article-title":"Novel therapies for cutaneous T-cell lymphoma: what does the future hold?","volume":"23","author":"Guenova","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jid.2026.03.035_bib33","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3390\/cells13070584","article-title":"The role of cytokines in cutaneous T cell lymphoma: a focus on the state of the art and possible therapeutic targets","volume":"13","author":"Guglielmo","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.jid.2026.03.035_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1646669","article-title":"Unraveling the role of chemokines in cutaneous T-cell lymphoma: expression levels at different stages","volume":"16","author":"Guglielmo","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2026.03.035_bib35","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jid.2023.10.023","article-title":"Role of antigenic stimulation in cutaneous T-cell lymphomas","volume":"144","author":"Gumina","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2017.12.012","article-title":"Regulation of the immune response by the aryl hydrocarbon receptor","volume":"48","author":"Guti\u00e9rrez-V\u00e1zquez","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2026.03.035_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41435-020-0095-7","article-title":"Evolution and function of interleukin-4 receptor signaling in adaptive immunity and neutrophils","volume":"21","author":"Heeb","year":"2020","journal-title":"Genes Immun"},{"key":"10.1016\/j.jid.2026.03.035_bib38","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1182\/blood.2020009346","article-title":"Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures","volume":"138","author":"Herrera","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib39","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.12788\/cutis.0074","article-title":"Long-standing dermatitis treated with dupilumab with subsequent progression to cutaneous T-cell lymphoma","volume":"106","author":"Hollins","year":"2020","journal-title":"Cutis"},{"key":"10.1016\/j.jid.2026.03.035_bib40","first-page":"1","article-title":"Mycosis fungoides is a proliferation of multiple mutational subclones","author":"Honda","year":"2026","journal-title":"J Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib41","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/exd.14108","article-title":"Methylation patterns of cutaneous T-cell lymphomas","volume":"30","author":"I\u017cykowska","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1182\/blood.V89.1.32.32_32_40","article-title":"Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion [published correction appears in Blood 1997;89:3496]","volume":"89","author":"Jackow","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib43","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jid.2023.10.018","article-title":"Deciphering tumor cell evolution in cutaneous T-cell lymphomas: distinct differentiation trajectories in mycosis fungoides and S\u00e9zary syndrome","volume":"144","author":"Jiang","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2003.132","article-title":"Thymus and activation-regulated chemokine (TARC\/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides","volume":"48","author":"Kakinuma","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib45","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S1470-2045(18)30379-6","article-title":"Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jid.2026.03.035_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00281-016-0594-9","article-title":"Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover","volume":"39","author":"Krejsgaard","year":"2017","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jid.2026.03.035_bib47","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/blood-2013-01-480889","article-title":"Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma","volume":"122","author":"Krejsgaard","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nri1310","article-title":"Immune surveillance in the skin: mechanisms and clinical consequences","volume":"4","author":"Kupper","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2026.03.035_bib49","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood.2024024817","article-title":"Genetic alteration of class I HLA in cutaneous T-cell lymphoma","volume":"145","author":"Kwang","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib50","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.3390\/cancers16193368","article-title":"The tumor microenvironment as a therapeutic target in cutaneous T cell lymphoma","volume":"16","author":"Kwantwi","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jid.2026.03.035_bib51","doi-asserted-by":"crossref","first-page":"34","DOI":"10.20892\/j.issn.2095-3941.2020.0216","article-title":"Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials","volume":"18","author":"Lai","year":"2021","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.jid.2026.03.035_bib52","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s40257-025-00955-7","article-title":"Cutaneous T cell lymphoma following dupilumab therapy in patients with atopic dermatitis: clinical review and recommendations","volume":"26","author":"Lavin","year":"2025","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib53","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/s41590-024-02018-1","article-title":"Cutaneous T cell lymphoma atlas reveals malignant TH2 cells supported by a B cell-rich tumor microenvironment [published correction appears in Nat Immunol 2025;26:147]","volume":"25","author":"Li","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2026.03.035_bib54","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/cells14040309","article-title":"The CD39\/CD73\/Adenosine and NAD\/CD38\/CD203a\/CD73 axis in cutaneous T-cell lymphomas","volume":"14","author":"Lin","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.jid.2026.03.035_bib55","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/blood.2018888107","article-title":"Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma","volume":"134","author":"Lindahl","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib56","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jid.2023.06.205","article-title":"Characteristics of Staphylococcus aureus colonization in cutaneous T-cell lymphoma","volume":"144","author":"Liu","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib57","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/jid.2009.122","article-title":"Chemokine receptors in T-cell-mediated diseases of the skin","volume":"129","author":"Lonsdorf","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib58","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1309\/3N7P-J84L-JQ9K-G89R","article-title":"The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides","volume":"115","author":"Lu","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jid.2026.03.035_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1258823","article-title":"Type 2 cytokines sensitize human sensory neurons to itch-associated stimuli","volume":"16","author":"Mack","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.jid.2026.03.035_bib60","doi-asserted-by":"crossref","first-page":"437","DOI":"10.5114\/pdia.2015.48034","article-title":"Expression of CXCR4 and CXCL12 and their correlations to the cell proliferation and angiogenesis in mycosis fungoides","volume":"32","author":"Maj","year":"2015","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.jid.2026.03.035_bib61","first-page":"245","article-title":"Role of IL-4 and IL-13 in cutaneous T cell lymphoma","volume":"14","author":"Mazzetto","year":"2024","journal-title":"Life (Basel)"},{"key":"10.1016\/j.jid.2026.03.035_bib62","article-title":"scRNA-Seq reveals anti-lymphoma immune responses in mogamulizumab-associated skin eruptions","author":"Meledathu","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2026.03.035_bib63","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/jid.2013.394","article-title":"Epidermal CCL27 expression is regulated during skin development and keratinocyte differentiation","volume":"134","author":"Mildner","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib64","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2230.2008.02990.x","article-title":"Increased serum thymic stromal lymphopoietin levels in patients with cutaneous T cell Lymphoma","volume":"34","author":"Miyagaki","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29575","article-title":"Prevalence, tropism, and activity of cutavirus in circulating blood lymphocytes, stool, and skin biopsy specimens of patients with cutaneous T-cell lymphoma and parapsoriasis en plaques","volume":"96","author":"Mohanraj","year":"2024","journal-title":"J Med Virol"},{"key":"10.1016\/j.jid.2026.03.035_bib66","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1182\/blood-2024-206462","article-title":"Dual-targeted therapy with Ruxolitinib plus Duvelisib for T-cell lymphoma","volume":"144","author":"Moskowitz","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib67","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1182\/blood.2021013379","article-title":"A phase 2 biomarker-driven study of Ruxolitinib demonstrates effectiveness of JAK\/STAT targeting in T-cell lymphomas","volume":"138","author":"Moskowitz","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115810","article-title":"Pro tumorigenic role of lower dermal fibroblasts and fibroblast-derived ECM in early mycosis fungoides","volume":"229","author":"Moyal","year":"2025","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jid.2026.03.035_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/S0959-8049(21)00648-1","article-title":"CXCR4\/CXCL12 axis as a potential therapeutic target in mycosis fungoides: an in-vitro study","volume":"156","author":"Moyal","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jid.2026.03.035_bib70","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.4161\/15384101.2014.965061","article-title":"Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression","volume":"13","author":"Netchiporouk","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jid.2026.03.035_bib71","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/eji.202049043","article-title":"CCR4 in cutaneous T-cell lymphoma: therapeutic targeting of a pathogenic driver","volume":"51","author":"Nicolay","year":"2021","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jid.2026.03.035_bib72","first-page":"146","article-title":"The expression of CXCR3 and CD30 in mycosis fungoides","volume":"15","author":"Nikoo","year":"2012","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.jid.2026.03.035_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.128","article-title":"Investigating heredity in cutaneous T-cell lymphoma in a unique cohort of Danish twins","volume":"7","author":"Odum","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jid.2026.03.035_bib74","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14099","article-title":"Serum CCL22 levels decreased in parallel with disease activity in CCR4-positive mycosis fungoides treated with mogamulizumab","volume":"33","author":"Ohuchi","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jid.2026.03.035_bib75","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2006.10.2434","article-title":"Phase IIB multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma","volume":"25","author":"Olsen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jid.2026.03.035_bib76","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.semcancer.2021.12.003","article-title":"Molecular pathogenesis of cutaneous T cell Lymphoma: role of chemokines, cytokines, and dysregulated signaling pathways","volume":"86","author":"Patil","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jid.2026.03.035_bib77","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3389\/fonc.2020.00765","article-title":"Update on biology of cutaneous T-cell lymphoma","volume":"10","author":"Phyo","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jid.2026.03.035_bib78","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.3390\/cells10102780","article-title":"The microenvironment\u2019s role in mycosis fungoides and S\u00e9zary syndrome: from progression to therapeutic implications","volume":"10","author":"Pileri","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jid.2026.03.035_bib79","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.1200\/JCO.2024.42.16_suppl.7082","article-title":"Lacutamab in patients with relapsed and\/or refractory mycosis fungoides: results from the TELLOMAK phase 2 trial","volume":"42","author":"Porcu","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jid.2026.03.035_bib80","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.0022-202X.2004.22326.x","article-title":"CD158k\/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome","volume":"122","author":"Poszepczynska-Guign\u00e9","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib81","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1182\/blood-2012-03-415638","article-title":"Mast cells play a protumorigenic role in primary cutaneous lymphoma","volume":"120","author":"Rabenhorst","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib82","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/cells11030333","article-title":"S\u00e9zary syndrome: different erythroderma morphological features with proposal for a clinical score system","volume":"11","author":"Roccuzzo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jid.2026.03.035_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100092","article-title":"Targeting the adenosinergic axis in cancer immunotherapy: insights into A2A and A2B receptors and novel clinical combination strategies","volume":"77","author":"Rodr\u00edguez-Pamp\u00edn","year":"2025","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jid.2026.03.035_bib84","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1182\/blood-2017-03-772996","article-title":"Circulating and skin-derived S\u00e9zary cells: clonal but with phenotypic plasticity","volume":"130","author":"Roelens","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib85","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.0906-6705.2004.00176.x","article-title":"Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma","volume":"13","author":"R\u00fcbben","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib86","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jid.2026.03.035_bib87","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1159\/000524033","article-title":"Staphylococcus aureus activates the aryl hydrocarbon receptor in human keratinocytes","volume":"14","author":"Stange","year":"2022","journal-title":"J Innate Immun"},{"key":"10.1016\/j.jid.2026.03.035_bib88","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/imr.12635","article-title":"Role of mast cells and basophils in pruritus","volume":"282","author":"Steinhoff","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jid.2026.03.035_bib89","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1158\/0008-5472.CAN-16-0992","article-title":"Thymic stromal chemokine TSLP acts through Th2 cytokine production to induce cutaneous T-cell lymphoma","volume":"76","author":"Takahashi","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2026.03.035_bib90","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/blood.2019004256","article-title":"Genetic and epigenetic insights into cutaneous T-cell lymphoma","volume":"139","author":"Tensen","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib91","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2133.1995.tb02485.x","article-title":"Cutaneous colonization with staphylococci influences the disease activity of S\u00e9zary syndrome: a potential role for bacterial superantigens","volume":"133","author":"Tokura","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib92","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3109\/10428194.2014.919634","article-title":"CCR4+T cell recruitment to the skin in mycosis fungoides: potential contributions by thymic stromal lymphopoietin and interleukin-16","volume":"56","author":"Tuzova","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jid.2026.03.035_bib93","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1182\/blood.2023021671","article-title":"Staphylococcus aureus induces drug resistance in cancer T cells in S\u00e9zary syndrome","volume":"143","author":"Vadivel","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib94","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1182\/blood-2017-11-764357","article-title":"Novel insights into the pathogenesis of T-cell lymphomas","volume":"131","author":"Van Arnam","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib95","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaad.2020.12.026","article-title":"The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: current and future approaches","volume":"84","author":"Weiner","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104559","article-title":"Skin barrier dysfunction in cutaneous T-cell lymphoma: from pathogenic mechanism of barrier damage to treatment","volume":"205","author":"Wen","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jid.2026.03.035_bib97","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1200\/JCO.2010.28.9066","article-title":"Final results from a multicenter, international, pivotal study of Romidepsin in refractory cutaneous T-cell lymphoma","volume":"28","author":"Whittaker","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jid.2026.03.035_bib98","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/ajh.24876","article-title":"Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management","volume":"92","author":"Wilcox","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jid.2026.03.035_bib99","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib100","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas [published correction appears in Blood 2019;134:1112]","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib101","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41408-020-0324-3","article-title":"Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in S\u00e9zary syndrome","volume":"10","author":"Willerslev-Olsen","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jid.2026.03.035_bib102","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.jid.2021.01.038","article-title":"Staphylococcus aureus induces signal transducer and activator of transcription 5\u2012dependent miR-155 expression in cutaneous T-cell lymphoma","volume":"141","author":"Willerslev-Olsen","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib103","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1182\/blood-2015-08-662353","article-title":"Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma","volume":"127","author":"Willerslev-Olsen","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib104","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2015-02-629543","article-title":"The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma","volume":"126","author":"Witzig","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib105","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1182\/blood-2004-03-1190","article-title":"Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15","volume":"104","author":"Wysocka","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.03.035_bib106","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.jid.2024.04.018","article-title":"Keratinocytes present Staphylococcus aureus enterotoxins and promote malignant and nonmalignant T cell proliferation in cutaneous T-cell lymphoma","volume":"144","author":"Zeng","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.035_bib107","article-title":"The chemokine receptor CCR8 is a target of chimeric antigen T cells for treating T cell malignancies","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2026.03.035_bib108","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2007.11.4207","article-title":"Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma","volume":"25","author":"Zinzani","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26010328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26010328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:32:22Z","timestamp":1786037542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X26010328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":110,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0022202X26010328"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2026.03.035","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis of cutaneous T-cell lymphoma: Malignant inflammation, immune reprogramming, and microenvironmental drivers","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2026.03.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}